
Australian Pharmaceutical Industries (ASX:API) share price on watch after profit guidance rise
Takeover target Australian Pharmaceutical Industries Ltd (ASX: API) share price is up marginally after the company upgraded profit guidance.
Buy good companies. Try not to overpay. Do nothing.
Terry Smith
Takeover target Australian Pharmaceutical Industries Ltd (ASX: API) share price is up marginally after the company upgraded profit guidance.
The Star Entertainment Group Ltd (ASX: SGR) share price has fallen 18% after a reports of suspected money laundering, organised crime, large-scale fraud and foreign interference within its Australian casinos.
The EML Payments Ltd (ASX:EML) share price will be on watch after the company released an update on regulatory action by the Central Bank of Ireland.
The battle for Australian Pharmaceutical (ASX: API) is heating up as Wesfarmers (ASX: WES) nab 19% stake in the local pharmacy chain.
The Appen Ltd (ASX: APX) share price has tumbled 66% since the start of 2021. However, I think the business could potentially be oversold.
Despite a sea of red on markets, the Redbubble Ltd (ASX: RBL) share price has soared 9% after Morgan Stanley initiated a $6.50 price target.
Magellan Financial Group’s Ltd (ASX: MFG) purchase of a 40% stake in Barrenjoey is derisking the company and adding new revenue streams.
Since its initial public offering in October 2020, the Aussie Broadband Ltd (ASX: ABB) share price 5-bagged over one year to now rest at $5.14. Where to from here?
Despite generating zero revenue, investors have scrambled to get a piece of the Li-S Energy Limited (ASX: LIS) IPO sending shares up 174% on its first day of trading.
Want to level-up your analytical skills and investing insights but don’t know where to start? Join 50,000 Australian investors on our mailing list and we’ll send you our favourite podcasts, courses, resources and investment articles every Sunday morning. Grab a coffee and let Owen and the team bring you the best insights.